We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.87%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$208M
AUM Growth
–
Cap. Flow
+$196M
Cap. Flow %
94.43%
Top 10 Hldgs %
50.65%
Holding
29
New
27
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$15.1M
2
ZGNX
Zogenix, Inc.
ZGNX
+$11.6M
3
RXDX
Ignyta, Inc.
RXDX
+$10.3M
4
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
+$9.78M
5
KODK icon
Kodak
KODK
+$9.78M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 36.89%
2 Consumer Discretionary 11.44%
3 Industrials 4.9%
4 Technology 4.74%
5 Communication Services 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNXL
26
DELISTED
Uni-Pixel, Inc.
UNXL
$1M 0.48%
+176,000
New +$964K
TVTX icon
27
Travere Therapeutics
TVTX
$5.2B
$427K 0.21%
+34,874
New +$361K
1
2

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Armistice Capital, which disclosed 29 positions worth $208M. Its ten largest holdings account for 51% of the portfolio.

Its largest position is Spectrum Pharmaceuticals Inc: 2,052,000 shares worth $14.2M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, followed by Consumer Discretionary and Industrials.

  • Armistice Capital's largest Q4 2014 buy was Spectrum Pharmaceuticals Inc: 2,052,000 shares worth $14.2M.
  • Armistice Capital's ten largest holdings make up 51% of its $208M portfolio in Q4 2014.
  • Armistice Capital disclosed 29 positions in Q4 2014, its first 13F filing on record.

Based on Armistice Capital's 13F filing for Q4 2014, filed 17 Feb 2015.